@article{ref1,
title="Psychiatric comorbidity in clinically stable COVID-19 patients",
journal="Indian journal of psychiatry",
year="2022",
author="Gaur, V. and Salvi, D. and Gautam, M. and Sangwan, V. and Tambi, T. and Kalia, A. and Singh, N.",
volume="64",
number="1",
pages="89-92",
abstract="Aims: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients. <br><br>MATERIALS AND METHODS: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 Self-Rated Level 1 CCSM - Adult scale. <br><br>RESULTS: The prevalence of psychiatric comorbidity was 76.4% (n = 55). Depression was the most common diagnosis in 44.44% (n = 32) followed by anxiety (34.72%, n = 25), somatic symptoms (26.39%, n = 19), sleep problems (23.61%, n = 17). Around 45.83 % (n = 33) patients considered COVID-19 infection as potentially life-threatening and 23.62% (n=17) patients experienced discrimination and stigma after being diagnosed with COVID-19 infection. Using binary logistic regression, physical symptoms was identified as a risk factor for psychiatric comorbidity. <br><br>CONCLUSION: Our study provides evidence of a significant impact of COVID-19 infection on mental health in COVID-19 patients. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.<p /><p>Language: en</p>",
language="en",
issn="0019-5545",
doi="10.4103/indianjpsychiatry.indianjpsychiatry_312_21",
url="http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_312_21"
}